Roman Hájek (R Hajek, Roman Hajek)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 63

Top Topics

Multiple Myeloma

Genome Wide Association

Top Venues

Blood cancer journal

British journal of haematology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Molly Went, Laura Duran-Lozano, Gisli Hreinn Halldorsson, Andrea Gunnell, Nerea Ugidos-Damboriena, Philip J Law, Ludvig Ekdahl, Amit Sud, Gudmar Thorleifsson, Malte Thodberg, Thorunn Asta Olafsdottir, Antton Lamarca-Arrizabalaga, Caterina Cafaro, Abhishek Niroula, Ram Ajore, Aitzkoa Lopez de Lapuente Portilla, Zain Ali, Maroulio Pertesi, Hartmut Goldschmidt, Lilja Stefansdottir, Sigurdur Y Kristinsson, Simon N Stacey, Thorvardur J Love, Saemundur Rognvaldsson, Roman Hájek, Pavel Vodicka, Ulrika Pettersson-Kymmer, Florentin Späth, Carolina D Schinke, Frits Van Rhee, Patrick Sulem, Egil Ferkingstad, Grimur Hjorleifsson Eldjarn, Ulf-Henrik Mellqvist, Ingileif Jónsdóttir, Gareth J Morgan, Pieter Sonneveld, Anders Waage, Niels Weinhold, Hauke Thomsen, Asta Försti, Markus Hansson, Annette Juul Vangsted, Unnur Thorsteinsdottir, Kari Hemminki, Martin F Kaiser, Thorunn Rafnar, Kári Stefánsson, Richard S Houlston, Björn Nilsson
Deciphering the genetics and mechanisms of predisposition to multiple myeloma. Nature communications 15 (1) (2024)
Tomas Jelinek, D Zihala, T Sevcikova, Anjana Anilkumar Sithara, V Kapustova, H Sahinbegovic, O Venglar, L Muronova, L Broskevicova, S Nenarokov, D Bilek, Tereza Popkova, H Plonkova, J Vrana, V Zidlik, P Hurnik, Martin Havel, Matous Hrdinka, Z Chyra, Giovanni Stracquadanio, Michal Simicek, Roman Hájek
Beyond the marrow: insights from comprehensive next-generation sequencing of extramedullary multiple myeloma tumors. Leukemia 38 (6) (2024)
Molly Went, Laura Duran-Lozano, Gisli Hreinn Halldorsson, Andrea Gunnell, Nerea Ugidos-Damboriena, Philip J Law, Ludvig Ekdahl, Amit Sud, Gudmar Thorleifsson, Malte Thodberg, Thorunn Asta Olafsdottir, Antton Lamarca-Arrizabalaga, Caterina Cafaro, Abhishek Niroula, Ram Ajore, Aitzkoa Lopez de Lapuente Portilla, Zain Ali, Maroulio Pertesi, Hartmut Goldschmidt, Lilja Stefansdottir, Sigurdur Y Kristinsson, Simon N Stacey, Thorvardur J Love, Saemundur Rognvaldsson, Roman Hájek, Pavel Vodicka, Ulrika Pettersson-Kymmer, Florentin Späth, Carolina D Schinke, Frits Van Rhee, Patrick Sulem, Egil Ferkingstad, Grimur Hjorleifsson Eldjarn, Ulf-Henrik Mellqvist, Ingileif Jónsdóttir, Gareth J Morgan, Pieter Sonneveld, Anders Waage, Niels Weinhold, Hauke Thomsen, Asta Försti, Markus Hansson, Annette Juul Vangsted, Unnur Thorsteinsdottir, Kari Hemminki, Martin F Kaiser, Thorunn Rafnar, Kári Stefánsson, Richard S Houlston, Björn Nilsson
Deciphering the genetics and mechanisms of predisposition to multiple myeloma. Nature communications 15 (1) (2024)
Tomas Jelinek, D Zihala, T Sevcikova, Anjana Anilkumar Sithara, V Kapustova, H Sahinbegovic, O Venglar, L Muronova, L Broskevicova, S Nenarokov, D Bilek, Tereza Popkova, H Plonkova, J Vrana, V Zidlik, P Hurnik, Martin Havel, Matous Hrdinka, Z Chyra, Giovanni Stracquadanio, Michal Simicek, Roman Hájek
Beyond the marrow: insights from comprehensive next-generation sequencing of extramedullary multiple myeloma tumors. Leukemia 38 (6) (2024)
Tomas Jelinek, D Zihala, T Sevcikova, Anjana Anilkumar Sithara, V Kapustova, H Sahinbegovic, O Venglar, L Muronova, L Broskevicova, S Nenarokov, D Bilek, Tereza Popkova, H Plonkova, J Vrana, V Zidlik, P Hurnik, Martin Havel, Matous Hrdinka, Z Chyra, Giovanni Stracquadanio, Michal Simicek, Roman Hájek
Beyond the marrow: insights from comprehensive next-generation sequencing of extramedullary multiple myeloma tumors. Leukemia 38 (6) (2024)
Dhwani Radhakrishnan, Jana Kotulová, Lucie Hofmanová, Anjana Anilkumar Sithara, Marcello Turi, David Zihala, Michal Durech, Jan Vrána, Valeria Uleri, Veronika Niederlova, Ondrej Stepanek, Zuzana Chyra, Tomas Jelinek, Roman Hájek, Matous Hrdinka
Deubiquitinase BAP1 is crucial for surface expression of T cell receptor (TCR) complex, T cell-B cell conjugate formation, and T cell activation. Journal of leukocyte biology (2024)
Hauke Thomsen, Subhayan Chattopadhyay, Niels Weinhold, Pavel Vodicka, Ludmila Vodickova, Per Hoffmann, Markus Maria Nöthen, Karl-Heinz Jöckel, Börge Schmidt, Roman Hájek, Göran Hallmans, Ulrika Pettersson-Kymmer, Florentin Späth, Hartmut Goldschmidt, Kari Hemminki, Asta Försti
Haplotype analysis identifies functional elements in monoclonal gammopathy of unknown significance. Blood cancer journal 14 (1) (2024)
Hauke Thomsen, Subhayan Chattopadhyay, Niels Weinhold, Pavel Vodicka, Ludmila Vodickova, Per Hoffmann, Markus Maria Nöthen, Karl-Heinz Jöckel, Börge Schmidt, Roman Hájek, Göran Hallmans, Ulrika Pettersson-Kymmer, Florentin Späth, Hartmut Goldschmidt, Kari Hemminki, Asta Försti
Haplotype analysis identifies functional elements in monoclonal gammopathy of unknown significance. Blood cancer journal 14 (1) (2024)
Tomas Jelinek, D Zihala, T Sevcikova, Anjana Anilkumar Sithara, V Kapustova, H Sahinbegovic, O Venglar, L Muronova, L Broskevicova, S Nenarokov, D Bilek, Tereza Popkova, H Plonkova, J Vrana, V Zidlik, P Hurnik, Martin Havel, Matous Hrdinka, Z Chyra, Giovanni Stracquadanio, Michal Simicek, Roman Hájek
Beyond the marrow: insights from comprehensive next-generation sequencing of extramedullary multiple myeloma tumors. Leukemia 38 (6) (2024)
Tomas Jelinek, D Zihala, T Sevcikova, Anjana Anilkumar Sithara, V Kapustova, H Sahinbegovic, O Venglar, L Muronova, L Broskevicova, S Nenarokov, D Bilek, Tereza Popkova, H Plonkova, J Vrana, V Zidlik, P Hurnik, Martin Havel, Matous Hrdinka, Z Chyra, Giovanni Stracquadanio, Michal Simicek, Roman Hájek
Beyond the marrow: insights from comprehensive next-generation sequencing of extramedullary multiple myeloma tumors. Leukemia (2024)
Molly Went, Laura Duran-Lozano, Gisli Hreinn Halldorsson, Andrea Gunnell, Nerea Ugidos-Damboriena, Philip J Law, Ludvig Ekdahl, Amit Sud, Gudmar Thorleifsson, Malte Thodberg, Thorunn Asta Olafsdottir, Antton Lamarca-Arrizabalaga, Caterina Cafaro, Abhishek Niroula, Ram Ajore, Aitzkoa Lopez de Lapuente Portilla, Zain Ali, Maroulio Pertesi, Hartmut Goldschmidt, Lilja Stefansdottir, Sigurdur Y Kristinsson, Simon N Stacey, Thorvardur J Love, Saemundur Rognvaldsson, Roman Hájek, Pavel Vodicka, Ulrika Pettersson-Kymmer, Florentin Späth, Carolina D Schinke, Frits Van Rhee, Patrick Sulem, Egil Ferkingstad, Grimur Hjorleifsson Eldjarn, Ulf-Henrik Mellqvist, Ingileif Jónsdóttir, Gareth J Morgan, Pieter Sonneveld, Anders Waage, Niels Weinhold, Hauke Thomsen, Asta Försti, Markus Hansson, Annette Juul Vangsted, Unnur Thorsteinsdottir, Kari Hemminki, Martin F Kaiser, Thorunn Rafnar, Kári Stefánsson, Richard S Houlston, Björn Nilsson
Deciphering the genetics and mechanisms of predisposition to multiple myeloma. Nature communications 15 (1) (2024)
Thomas G Martin, Meletios- Athanasios Dimopoulos, Joseph R Mikhael, Kwee L Yong, Marcelo Capra, Thierry Facon, Roman Hájek, Ivan Špička, Ross Baker, Kihyun Kim, Gracia Martinez, Chang-Ki Min, Ludek Pour, Xavier Leleu, Albert Ortiol, Youngil Koh, Kenshi Suzuki, France Casca, Sandrine Macé, Marie-Laure Risse, Philippe Moreau
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study. Blood cancer journal 13 (1) (2023)
Daisuke Ogiya, Zuzana Chyra, Sigitas J Verselis, Morgan O'Keefe, Jacquelyn Cobb, Ivane Abiatari, Srikanth Talluri, Anjana Anilkumar Sithara, Teru Hideshima, Michael P Chu, Roman Hájek, David M Dorfman, Linda M Pilarski, Kenneth C Anderson, Sophia Adamia
Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics. Blood cancer journal 13 (1) (2023)
Daisuke Ogiya, Zuzana Chyra, Sigitas J Verselis, Morgan O'Keefe, Jacquelyn Cobb, Ivane Abiatari, Srikanth Talluri, Anjana Anilkumar Sithara, Teru Hideshima, Michael P Chu, Roman Hájek, David M Dorfman, Linda M Pilarski, Kenneth C Anderson, Sophia Adamia
Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics. Blood cancer journal 13 (1) (2023)
Giovanni Palladini, Stefan O Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios- Athanasios Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M Teresa Cibeira, Hermine Agis, Monique C Minnema, Rui Bergantim, Roman Hájek, Cristina Joao, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh D Wechalekar
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood cancer journal 13 (1) (2023)
Daisuke Ogiya, Zuzana Chyra, Sigitas J Verselis, Morgan O'Keefe, Jacquelyn Cobb, Ivane Abiatari, Srikanth Talluri, Anjana Anilkumar Sithara, Teru Hideshima, Michael P Chu, Roman Hájek, David M Dorfman, Linda M Pilarski, Kenneth C Anderson, Sophia Adamia
Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics. Blood cancer journal 13 (1) (2023)
Daisuke Ogiya, Zuzana Chyra, Sigitas J Verselis, Morgan O'Keefe, Jacquelyn Cobb, Ivane Abiatari, Srikanth Talluri, Anjana Anilkumar Sithara, Teru Hideshima, Michael P Chu, Roman Hájek, David M Dorfman, Linda M Pilarski, Kenneth C Anderson, Sophia Adamia
Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics. Blood cancer journal 13 (1) (2023)
Benjamin Motais, Sandra Charvátová, Zuzana Walek, Roman Hájek, Juli Rodriguez Bago
NK92 Expressing Anti-BCMA CAR and Secreted TRAIL for the Treatment of Multiple Myeloma: Preliminary In Vitro Assessment. Cells 12 (23) (2023)
Ondrej Venglar, Veronika Kapustova, Anjana Anilkumar Sithara, David Zihala, Ludmila Muronova, Tereza Sevcikova, Jan Vrana, Alexander Vdovin, Jakub Radocha, Petra Krhovska, Matous Hrdinka, Michal Turjap, Tereza Popkova, Zuzana Chyra, Lucie Broskevicova, Michal Simicek, Zdenek Koristek, Roman Hájek, Tomas Jelinek
Insight into the mechanism of CD34 + cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapy. British journal of haematology (2023)
Thomas G Martin, Meletios- Athanasios Dimopoulos, Joseph R Mikhael, Kwee L Yong, Marcelo Capra, Thierry Facon, Roman Hájek, Ivan Špička, Ross Baker, Kihyun Kim, Gracia Martinez, Chang-Ki Min, Ludek Pour, Xavier Leleu, Albert Ortiol, Youngil Koh, Kenshi Suzuki, France Casca, Sandrine Macé, Marie-Laure Risse, Philippe Moreau
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study. Blood cancer journal 13 (1) (2023)
Christian Buske, Meletios- Athanasios Dimopoulos, Alexander Grunenberg, Efstathios Kastritis, Cécile Tomowiak, Béatrice Mahé, Xavier Troussard, Roman Hájek, Andreas Viardot, Olivier Tournilhac, Therese Aurran, Stephane Lepretre, Hacene Zerazhi, Benedicte Hivert, Veronique Leblond, Sophie de Guibert, Lena Brandefors, Miriam Santero, Maria Gomes da Silva, Eva Kimby, Birgit Schmelzle, Dajana Kaszynski, Jens Dreyhaupt, Rainer Muche, Pierre Morel
Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's Macroglobulinemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Giovanni Palladini, Stefan O Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios- Athanasios Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M Teresa Cibeira, Hermine Agis, Monique C Minnema, Rui Bergantim, Roman Hájek, Cristina Joao, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh D Wechalekar
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood cancer journal 13 (1) (2023)
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, Michel Delforge, Curly T C M Morris, Francesca Gay, Niels W C J van de Donk, Ioannis Ntanasis-Stathopoulos, Annette Juul Vangsted, Christoph Driessen, Schjesvold Fredrik, Claudio Cerchione, Sonja Zweegman, Roman Hájek, Phillipe Moreau, Hermann Einsele, Jesús San F Miguel, Mario Boccadoro, Meletios- Athanasios Dimopoulos, Pieter Sonneveld, Heinz Ludwig
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN). Leukemia (2023)
Daisuke Ogiya, Zuzana Chyra, Sigitas J Verselis, Morgan O'Keefe, Jacquelyn Cobb, Ivane Abiatari, Srikanth Talluri, Anjana Anilkumar Sithara, Teru Hideshima, Michael P Chu, Roman Hájek, David M Dorfman, Linda M Pilarski, Kenneth C Anderson, Sophia Adamia
Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics. Blood cancer journal 13 (1) (2023)
Giovanni Palladini, Stefan O Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios- Athanasios Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M Teresa Cibeira, Hermine Agis, Monique C Minnema, Rui Bergantim, Roman Hájek, Cristina Joao, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh D Wechalekar
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood cancer journal 13 (1) (2023)
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, Michel Delforge, Curly T C M Morris, Francesca Gay, Niels W C J van de Donk, Ioannis Ntanasis-Stathopoulos, Annette Juul Vangsted, Christoph Driessen, Schjesvold Fredrik, Claudio Cerchione, Sonja Zweegman, Roman Hájek, Phillipe Moreau, Hermann Einsele, Jesús San F Miguel, Mario Boccadoro, Meletios- Athanasios Dimopoulos, Pieter Sonneveld, Heinz Ludwig
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN). Leukemia (2023)
Thomas G Martin, Meletios- Athanasios Dimopoulos, Joseph R Mikhael, Kwee L Yong, Marcelo Capra, Thierry Facon, Roman Hájek, Ivan Špička, Ross Baker, Kihyun Kim, Gracia Martinez, Chang-Ki Min, Ludek Pour, Xavier Leleu, Albert Ortiol, Youngil Koh, Kenshi Suzuki, France Casca, Sandrine Macé, Marie-Laure Risse, Philippe Moreau
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study. Blood cancer journal 13 (1) (2023)
Daisuke Ogiya, Zuzana Chyra, Sigitas J Verselis, Morgan O'Keefe, Jacquelyn Cobb, Ivane Abiatari, Srikanth Talluri, Anjana Anilkumar Sithara, Teru Hideshima, Michael P Chu, Roman Hájek, David M Dorfman, Linda M Pilarski, Kenneth C Anderson, Sophia Adamia
Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics. Blood cancer journal 13 (1) (2023)
Leire Burgos, Luis Esteban Tamariz-Amador, Noemi Puig, María-Teresa Cedena, Camilla Guerrero, Tomas Jelinek, Sarah Johnson, Paolo Milani, Lourdes Cordon, Jose J Perez, Marta Lasa, Rosalinda Termini, Albert Ortiol, Miguel-Teodoro T Hernandez Garcia, Luis Palomera, Rafael Martinez-Martinez, Javier de la Rubia, Felipe de Arriba, Rafael Rios-Tamayo, Maria-Esther Gonzalez, Mercedes Gironella, Valentín Cabañas, Maria Casanova, Isabel Krsnik, Albert Perez-Montaña, Verónica González De La Calle, Paula Rodriguez Otero, Vladimir Maisnar, Roman Hájek, Frits Van Rhee, Victor Jimenez-Zepeda, Giovanni Palladini, Giampaolo Merlini, Alberto Orfao, Javier de la Cruz, Joaquin Martinez Lopez, Juan-José Lahuerta, Laura Rosinol, Joan Blade, Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Juan José Lahuerta, null null
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Thomas G Martin, Meletios- Athanasios Dimopoulos, Joseph R Mikhael, Kwee L Yong, Marcelo Capra, Thierry Facon, Roman Hájek, Ivan Špička, Ross Baker, Kihyun Kim, Gracia Martinez, Chang-Ki Min, Ludek Pour, Xavier Leleu, Albert Ortiol, Youngil Koh, Kenshi Suzuki, France Casca, Sandrine Macé, Marie-Laure Risse, Philippe Moreau
Correction: Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study. Blood cancer journal 13 (1) (2023)
Giovanni Palladini, Stefan O Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios- Athanasios Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M Teresa Cibeira, Hermine Agis, Monique C Minnema, Rui Bergantim, Roman Hájek, Cristina Joao, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh D Wechalekar
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood cancer journal 13 (1) (2023)
Thomas G Martin, Meletios- Athanasios Dimopoulos, Joseph R Mikhael, Kwee L Yong, Marcelo Capra, Thierry Facon, Roman Hájek, Ivan Špička, Ross Baker, Kihyun Kim, Gracia Martinez, Chang-Ki Min, Ludek Pour, Xavier Leleu, Albert Ortiol, Youngil Koh, Kenshi Suzuki, France Casca, Sandrine Macé, Marie-Laure Risse, Philippe Moreau
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study. Blood cancer journal 13 (1) (2023)
Giovanni Palladini, Stefan O Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios- Athanasios Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M Teresa Cibeira, Hermine Agis, Monique C Minnema, Rui Bergantim, Roman Hájek, Cristina Joao, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh D Wechalekar
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood cancer journal 13 (1) (2023)
Alyssa Clay-Gilmour, Subhayan Chattopadhyay, Michelle A T Hildebrandt, Hauke Thomsen, Niels Weinhold, Pavel Vodicka, Ludmila Vodickova, Per Hoffmann, Markus Maria Nöthen, Karl-Heinz Jöckel, Börge Schmidt, Christian Langer, Roman Hájek, Göran Hallmans, Ulrika Pettersson-Kymmer, Claes Ohlsson, Florentin Späth, Richard S Houlston, Hartmut Goldschmidt, Elisabet E Manasanch, Aaron Norman, Shaji K Kumar, Sundararajan Vincent Rajkumar, Susan L Slager, Asta Försti, Celine M Vachon, Kari Hemminki
Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6. Blood cancer journal 12 (4) (2022)
Carl Ola Landgren, Katja Weisel, Laura Rosinol, Cyrille Touzeau, Mehmet Turgut, Roman Hájek, Peter Mollee, Jin Seok Kim, Natalie Shu, Xuguang Hu, Chuang Li, Saad Z Usmani
Subgroup analysis based on cytogenetic risk in patients with relapsed or refractory multiple myeloma in the CANDOR study. British journal of haematology 198 (6) (2022)
Larissa Haertle, Santiago Barrio, Umair Munawar, Seungbin Han, Xiang Zhou, Michal Simicek, Cornelia Vogt, Marietta Truger, Rafael Alonso Fernández, Maximilian Johannes Steinhardt, Julia Weingart, Renata Snaurova, Silvia Nerreter, Eva Teufel, Andoni Garitano-Trojaola, Matteo Claudio Da Via, Yanira Ruiz-Heredia, Andreas Rosenwald, Niccolo' Bolli, Roman Hájek, Peter Raab, Marc-Steffen Raab, Niels Weinhold, Claudia Haferlach, Thomas Haaf, Joaquin Martinez Lopez, Hermann Einsele, Leo Rasche, Klaus Martin Kortüm
Single Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Rosalinda Termini, David Zihala, Evangelos Terpos, Albert Perez-Montaña, Tomas Jelinek, Marc-Steffen Raab, Niels Weinhold, Elias Karl Mai, Anna Luise Grab, Jill Corre, François Vergez, Antonio Sacco, Marco Chiarini, Viviana Giustini, Alessandra Tucci, Sara Rodriguez, Cristina Moreno, Cristina Perez, Catarina Maia, Esperanza Martin-Sanchez, Camilla Guerrero, Cirino Botta, Juan-José Garcés, Aitziber Lopez, Luis Esteban Tamariz-Amador, Felipe Prosper, Joan Bargay, Maria-Elena Cabezudo, Enrique María Ocio, Roman Hájek, Joaquin Martinez Lopez, Fernando Solano, Rebeca Iglesias, Artur Paiva, Catarina Geraldes, Helena Vitoria, Clara Gomez, Felipe De Arriba, Heinz Ludwig, Antoni Garcia-Guiñon, María Casanova, Adrian Alegre, Valentín Cabañas, Maialen Sirvent, Albert Ortiol, Javier de la Rubia, Jose-Ángel Hernández-Rivas, Luis Palomera, Maria Sarasa, Pablo Rios, Noemi Puig, Maria-Victoria Mateos-Manteca, Juan A Flores-Montero, Alberto Orfao, Hartmut Goldschmidt, Herve Avet-Loiseau, Aldo M Roccaro, Jesús San F Miguel, Juan José Lahuerta, null null
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Ondrej Šušol, Barbora Hájková, Hana Zelená, Roman Hájek
Third dose of COVID-19 vaccine restores immune response in patients with haematological malignancies after loss of protective antibody titres. British journal of haematology 197 (3) (2022)
Thomas Martin, Joseph R Mikhael, Roman Hájek, Kihyun Kim, Kenshi Suzuki, Cyrille Hulin, Mamta Garg, Hang Quach, Hanlon Sia, Anup George, Tatyana S Konstantinova, Marie-Laure Risse, Gaelle Asset, Sandrine Macé, Helgi van de Velde, Philippe Moreau
Depth of response and response kinetics of isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma. Blood advances 6 (15) (2022)
Tomas Jelinek, Renata Bezděková, David Zihala, Tereza Ševčíková, Anjana Anilkumar Sithara, Lenka Pospisilova, Sabina Sevcikova, Petra Polackova, Martin Stork, Zdenka Knechtova, Ondrej Venglar, Veronika Kapustová, Tereza Popkova, Ludmila Muronova, Zuzana Chyra, Matous Hrdinka, Michal Simicek, Juan-José Garcés, Noemi Puig, María-Teresa Cedena, Artur Jurczyszyn, Jorge J Castillo, Miroslav Penka, Jakub Radocha, Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Juan José Lahuerta, Ludek Pour, Lucie Říhová, Roman Hájek
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Viera Sandecká, Luděk Pour, Ivan Špička, Jiří Minařík, Jakub Radocha, Tomáš Jelínek, Adriana Heindorfer, Petr Pavlíček, Michal Sýkora, Alexandra Jungová, Petr Kessler, Marek Wróbel, David Starostka, Jana Ullrychová, Lukáš Stejskal, Martin Stork, Jan Straub, Tomáš Pika, Lucie Brožová, Sabina Sevcikova, Vladimír Maisnar, Roman Hájek
Bortezomib-based therapy for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation: Czech Registry Data. European journal of haematology 107 (4) (2021)
Martin Stork, Sabina Sevcikova, Jiri Minarik, Petra Krhovska, Jakub Radocha, Lenka Pospisilova, Lucie Brozova, Jiri Jarkovsky, Ivan Spicka, Jan Straub, Petr Pavlicek, Alexandra Jungova, Tomas Jelinek, Viera Sandecka, Vladimir Maisnar, Roman Hájek, Ludek Pour
Identification of patients at high risk of secondary extramedullary multiple myeloma development. British journal of haematology (2021)
David L Murray, Noemi Puig, Sigurdur Kristinsson, Saad Z Usmani, Angela Dispenzieri, Giada Bianchi, Shaji K Kumar, Wee Joo Chng, Roman Hájek, Juan José Lahuerta, Anders Waage, Sundararajan Vincent Rajkumar, Brian Durie
Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report. Blood cancer journal 11 (2) (2021)
Tomas Jelinek, Tereza Sevcikova, David Zihala, Tereza Popkova, Veronika Kapustova, Lucie Broskevicova, Lenka Capkova, Lucie Rihova, Renata Bezdekova, Sabina Sevcikova, Vladimir Zidlik, Martin Havel, Hana Plonkova, Alexandra Jungova, Jiri Minarik, Martin Stork, Ludek Pour, Petr Pavlicek, Ivan Spicka, Vladimir Maisnar, Jakub Radocha, Michal Simicek, Roman Hájek
Limited efficacy of daratumumab in multiple myeloma with extramedullary disease. Leukemia (2021)
Renata Bezděková, Tomas Jelinek, Romana Kralova, Martin Stork, Petra Polackova, Pavla Vsianska, Lucie Brozova, Jiri Jarkovsky, Martina Almasi, Ivanna Boichuk, Zdenka Knechtova, Miroslav Penka, Ludek Pour, Sabina Sevcikova, Roman Hájek, Lucie Říhová
Necessity of flow cytometry assessment of circulating plasma cells and its connection with clinical characteristics of primary and secondary plasma cell leukaemia. British journal of haematology 195 (1) (2021)
Roman Hájek, Jiří Minařík, Jan Straub, Luděk Pour, Alexandra Jungova, Jesus G Berdeja, Mario Boccadoro, Lucie Brozova, Andrew Spencer, Frits van Rhee, Jorge Vela-Ojeda, Michael A Thompson, Rafat Abonour, Ajai Chari, Gordon Cook, Caitlin L Costello, Faith E Davies, Vania Tm Hungria, Hans C Lee, Xavier Leleu, Noemi Puig, Robert M Rifkin, Evangelos Terpos, Saad Z Usmani, Katja C Weisel, Jeffrey A Zonder, Magda Bařinová, Matyáš Kuhn, Jiří Šilar, Lenka Čápková, Kenny Galvez, Jin Lu, Jennifer Elliott, Dawn Marie Stull, Kaili Ren, Vladimír Maisnar
Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myeloma. Future oncology (London, England) 17 (19) (2021)
Gian Maria Zaccaria, Luca Bertamini, Maria Teresa Petrucci, Massimo Offidani, Paolo Corradini, Andrea Capra, Alessandra Romano, Anna Marina Liberati, Donato Mannina, Paolo de Fabritiis, Nicola Cascavilla, Marina Ruggeri, Roberto Mina, Francesca Patriarca, Giulia Benevolo, Angelo Belotti, Gianluca Gaidano, Arnon Nagler, Roman Hájek, Andrew Spencer, Pieter Sonneveld, Pellegrino Musto, Mario Boccadoro, Francesca Gay
Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (13) (2021)
Laura Rosinol, Meral Beksac, Elena Zamagni, Niels W C J Van de Donk, Kenneth C Anderson, Ashraf Badros, Jo Caers, Michele Cavo, Meletios- Athanasios Dimopoulos, Angela Dispenzieri, Hermann Einsele, Monika Engelhardt, Carlos Fernández de Larrea, Gösta Gahrton, Francesca Gay, Roman Hájek, Vania Hungria, Artur Jurczyszyn, Nicolaus Kröger, Robert A Kyle, Fernando Leal da Costa, Xavier Leleu, Suzanne Lentzsch, Maria-Victoria Mateos-Manteca, Giampaolo Merlini, Mohamad Mohty, Phillipe Moreau, Leo Rasche, Donna Reece, Orhan Sezer, Pieter Sonneveld, Saad Z Usmani, Karin Vanderkerken, David H Vesole, Anders Waage, Sonja Zweegman, Paul Gerard Richardson, Joan Bladé
Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations. British journal of haematology 194 (3) (2021)
Mattia D'Agostino, Alessandra Larocca, Massimo Offidani, Anna Marina Liberati, Gianluca Gaidano, Maria Teresa Petrucci, Daniele Derudas, Andrea Capra, Renato Zambello, Nicola Cascavilla, Paolo de Fabritiis, Vanessa Innao, Francesca Bonello, Francesca Patriarca, Giulia Benevolo, Nicola Giuliani, Gabriele Aitoro, Tommasina Guglielmelli, Francesco Di Raimondo, Paolo Corradini, Pellegrino Musto, Roman Hájek, Pieter Sonneveld, Mario Boccadoro, Sara Bringhen
Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score. Blood cancer journal 11 (4) (2021)
Evangelos Terpos, Joseph Mikhael, Roman Hájek, Ajai Chari, Sonja Zweegman, Hans C Lee, Maria-Victoria Mateos-Manteca, Alessandra Larocca, Karthik Ramasamy, Martin F Kaiser, Gordon Cook, Katja C Weisel, Caitlin L Costello, Jennifer Elliott, Antonio Palumbo, Saad Z Usmani
Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life. Blood cancer journal 11 (2) (2021)
Andrea Knight, Lucie Říhová, Romana Kralova, Miroslav Penka, Zdenek Adam, Ludek Pour, Martin Piskacek, Roman Hájek
Plasmacytoid Dendritic Cells in Patients with MGUS and Multiple Myeloma. Journal of clinical medicine 10 (16) (2021)
Heinz Ludwig, Bela Hausmann, Martin Schreder, Wolfram Pönisch, Niklas Zojer, Stefan Knop, Eberhard Gunsilius, Alexander Egle, Andreas Petzer, Hermann Einsele, Roman Hájek, Katja Weisel, Karl Jochen Krenosz, Alois Lang, Daniel Lechner, Richard Greil, David Berry
Reduced alpha diversity of the oral microbiome correlates with short progression-free survival in patients with relapsed/refractory multiple myeloma treated with ixazomib-based therapy (AGMT MM 1, phase II trial). EJHaem 2 (1) (2020)
Ivo Demel, Julio Rodriguez Bago, Roman Hájek, Tomas Jelinek
Focus on monoclonal antibodies targeting B-cell maturation antigen (BCMA) in multiple myeloma: update 2021. British journal of haematology 193 (4) (2020)
Tereza Popkova, Roman Hájek, Tomas Jelinek
Monoclonal antibodies in the treatment of AL amyloidosis: co-targetting the plasma cell clone and amyloid deposits. British journal of haematology 189 (2) (2020)
Roman Hájek, Sebastian Gonzalez-McQuire, Zsolt Szabo, Michel Delforge, Lucy DeCosta, Marc S Raab, Walter Bouwmeester, Marco Campioni, Andrew Briggs
Novel risk stratification algorithm for estimating the risk of death in patients with relapsed multiple myeloma: external validation in a retrospective chart review. BMJ open 10 (7) (2020)
Evangelos Terpos, Karthik Ramasamy, Nadjoua Maouche, Jiří Minařík, Ioannis Ntanasis-Stathopoulos, Eirini Katodritou, Matthew W Jenner, Hana Plonkova, Maria Gavriatopoulou, Grant D Vallance, Tomas Pika, Maria Kotsopoulou, Jaimal Kothari, Tomas Jelinek, Efstathios Kastritis, Robin Aitchison, Meletios- Athanasios Dimopoulos, Athanasios Zomas, Roman Hájek
Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma. Annals of hematology 99 (5) (2020)
Roman Hájek, Ludek Pour, Muhit Ozcan, Jesus Martin Sánchez, Ramon García Sanz, Achilles Anagnostopoulos, Albert Oriol, Nicola Cascavilla, Andreas Terjung, Yihua Lee, Eva M Briso, Edyta Dobkowska, Bernhard Hauns, Ivan Špička
A phase 2 study of ibrutinib in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma. European journal of haematology 104 (5) (2020)
Roman Hájek, Viera Sandecka, Ivan Špička, Marc-Steffen Raab, Hartmut Goldschmidt, Susanne Beck, Jiří Minařík, Petr Pavlíček, Jakub Radocha, Adriana Heindorfer, Tomáš Jelínek, Lukáš Stejskal, Lucie Brožová, Sabina Sevcikova, Jan Straub, Tomáš Pika, Luděk Pour, Vladimír Maisnar, Anja Seckinger, Dirk Hose
Identification of patients with smouldering multiple myeloma at ultra-high risk of progression using serum parameters: the Czech Myeloma Group model. British journal of haematology 190 (2) (2020)
Heinz Ludwig, Mario Boccadoro, Philippe Moreau, Jesus San-Miguel, Michele Cavo, Charlotte Pawlyn, Sonja Zweegman, Thierry Facon, Christoph Driessen, Roman Hájek, Melitios A Dimopoulos, Francesca Gay, Hervé Avet-Loiseau, Evangelos Terpos, Niklas Zojer, Mohamad Mohty, Maria-Victoria Mateos-Manteca, Hermann Einsele, Michel Delforge, Jo Caers, Katja Weisel, Graham Jackson, Laurent Garderet, Monika Engelhardt, Niels van de Donk, Xavier Leleu, Hartmut Goldschmidt, Meral Beksac, Inger Nijhof, Niels Abildgaard, Sara Bringhen, Pieter Sonneveld
Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network. Leukemia 35 (1) (2020)
Paul Gerard Richardson, Arnon Nagler, Dina Ben-Yehuda, Ashraf Badros, Parameswaran N Hari, Roman Hájek, Ivan Spicka, Hakan Kaya, Richard LeBlanc, Sung-Soo Yoon, Kihyun Kim, Joaquin Martinez-Lopez, Moshe Mittelman, Ofer Shpilberg, Paul Blake, Teru Hideshima, Kathleen Colson, Jacob P Laubach, Irene M Ghobrial, Merav Leiba, Moshe E E Gatt, Peter Sportelli, Michael Chen, Kenneth C Anderson
Randomized, placebo-controlled, phase 3 study of perifosine combined with bortezomib and dexamethasone in patients with relapsed, refractory multiple myeloma previously treated with bortezomib. EJHaem 1 (1) (2020)
David Vrabel, Lenka Sedlarikova, Lenka Besse, Lucie Rihova, Renata Bezdekova, Martina Almasi, Veronika Kubaczkova, Lucie Brožová, Jiri Jarkovsky, Hana Plonkova, Tomas Jelinek, Viera Sandecka, Martin Stork, Ludek Pour, Sabina Sevcikova, Roman Hájek
Dynamics of tumor-specific cfDNA in response to therapy in multiple myeloma patients. European journal of haematology 104 (3) (2019)
Roman Hájek, Michel Delforge, Marc-Steffen Raab, Paul Schoen, Lucy DeCosta, Ivan Spicka, Jakub Radocha, Ludek Pour, Sebastian Gonzalez-McQuire, Walter Bouwmeester
Development and validation of a novel risk stratification algorithm for relapsed multiple myeloma. British journal of haematology 187 (4) (2019)
Artur Jurczyszyn, Jakub Radocha, Julio Davila, Mark A Fiala, Alessandro Gozzetti, Norbert Grząśko, Paweł Robak, Iwona Hus, Anna Waszczuk-Gajda, Renata Guzicka-Kazimierczak, Erden Atilla, Giuseppe Mele, Waldemar Sawicki, David S Jayabalan, Grzegorz Charliński, Agoston G Szabo, Roman Hájek, Michel Delforge, Agnieszka Kopacz, Dorotea Fantl, Anders Waage, Irit Avivi, Marek Rodzaj, Xavier Leleu, Valentine Richez, Wanda Knopińska-Posłuszny, Anna Masternak, Andrew J Yee, Agnieszka Barchnicka, Agnieszka Druzd-Sitek, Thomas Guerrero-Garcia, Jieqi Liu, David H Vesole, Jorge J Castillo
Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients. British journal of haematology 180 (6) (2018)